DRTS
Alpha Tau Med (DRTS)
NASDAQ
$11.44-$0.35 (-3.01%)
Price as of Aug 03, 2026 6:31 AM EDT
  • $393.1M
    Market Cap
  • 295.64%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
HIGHTOWER ADVISORS, LLC
0.97%
874,994
+188,440 (+21.54%)
Mar 31, 2026
N/A
0.80%
721,501
+721,501 (+100.00%)
Mar 31, 2026
APELLA CAPITAL, LLC
0.42%
382,284
0 (0.00%)
Mar 31, 2026
ARK INVESTMENT MANAGEMENT LLC
0.32%
292,134
+292,134 (+100.00%)
Mar 31, 2026
UBS GROUP AG
0.32%
286,688
+265,988 (+92.78%)
Mar 31, 2026
HOYLECOHEN, LLC
0.30%
269,088
0 (0.00%)
Jun 30, 2024
KOVITZ INVESTMENT GROUP PARTNERS, LLC
0.16%
147,138
-10,720 (-7.29%)
Mar 31, 2026

Current Ownership Distribution

  • Other60.2M (66.67%)
  • Institutions22.6M (25.02%)
  • Mutual Funds4.6M (5.14%)
  • Insiders2.9M (3.18%)

Insider Transactions

  • 3.18% (2.9M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 1
    Number of InsiderSelling (last 12 months)
  • $5.7M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Levy Raphi
Chief Financial Officer
Exempt
Jul 06, 2026
$6,764.60
2,270
$2.98
92,450
Levy Raphi
Chief Financial Officer
Sell
Jul 06, 2026
$31,782.50
2,270
$14.00
90,180
Levy Raphi
Chief Financial Officer
Exempt
Jul 02, 2026
$53,261.54
17,873
$2.98
108,053
Levy Raphi
Chief Financial Officer
Sell
Jul 02, 2026
$232,397.26
17,873
$13.00
90,180
Levy Raphi
Chief Financial Officer
Exempt
Jul 01, 2026
$6,338.46
2,127
$2.98
92,307
Levy Raphi
Chief Financial Officer
Sell
Jul 01, 2026
$27,691.20
2,127
$13.02
90,180
Levy Raphi
Chief Financial Officer
Sell
Jun 25, 2026
$46,442.84
4,222
$11.00
125,958
Levy Raphi
Chief Financial Officer
Sell
Jun 25, 2026
$173,561.16
15,778
$11.00
110,180